Occasional hyaline degeneration in arteriolar walls was observed. Open in a separate window Fig. Immunofluorescence showed mesangial positivity for IgA and C3. Immunohistochemistry staining showed common IgG4 and improved CD38 and CD138 manifestation. Electron microscopy showed immune complexes located on the tubular basement membrane. He was diagnosed with IgAN and IgG4-TIN. He received glucocorticoids, leflunomide and tacrolimus to induce remission. He was given tacrolimus as long-term maintenance treatment. When tacrolimus was temporarily withdrawn, proteinuria recurred. Amadacycline methanesulfonate After resuming tacrolimus therapy, he again came into total remission. After 45?weeks of therapy, he remains in complete remission and the serum IgG4 level is normal. Conclusions The getting of concurrent IgAN and IgG4-TIN without abnormalities in renal function, imaging or extra-renal cells is definitely rare and their coexistence may be coincidental. Long-term treatment with tacrolimus proved effective and he offers remained in remission during 45?weeks follow-up. Keywords: IgA nephropathy, IgG4-related tubulointerstitial nephritis, Tacrolimus, Serum IgG4 Background IgA nephropathy (IgAN) is the most common cause of primary glomerulonephritis worldwide [1], and is particularly common among Asians [2]. Predominant IgA deposition in the glomerular mesangium by biopsy has been used as the defining characteristics for the analysis of IgAN [3]. IgAN was the most YWHAB common glomerulopathy, having a rate of recurrence of 28.1% [4]. IgG4-related disease (IgG4-RD) is an fibroinflammatory condition involved multiple organs characterized by IgG4 positive plasma cells infiltration in the involved tissues and elevated serum IgG4 level [5], having a prevalence of IgG4-RD in Japan estimated as 0.28C1.08/100,000 people in 2012 [6]. IgG4-related tubulointerstitial nephritis (IgG4-TIN), is the common manifestation of IgG4-related kidney disease (IgG4-RKD), accounting for about 15C25% of all Amadacycline methanesulfonate IgG4-RD [5, 7]. Glomerular disease in individuals with IgG4-RD has been reported in the establishing of IgG4-TIN, but most such individuals had extrarenal involvement and multiorgan involvement [8C10]. Only one case co-existing IgAN and IgG4-TIN has been reported, with dacryoadenitis and sialadenitis, but treatment was not discussed [5]. The co-occurrence of IgAN and IgG4-TIN without extrarenal involvement has not been previously reported. While glucocorticoids are recommended as the first-line therapy for IgG4-TIN, the part of tacrolimus like a long-term maintenance treatment has no report. Tacrolimus efficiently reduces proteinuria in IgAN [11]. Here we statement the case of a man who developed IgAN and IgG4-TIN without extra-renal manifestations and was treated with tacrolimus as maintenance therapy during Amadacycline methanesulfonate 45?weeks of follow-up. Case demonstration Clinical history and initial laboratory data A 56-year-old Chinese man was admitted with the chief problem of foamy urine for 1 year and hematuria for 3 months. Medical history was notable for hypertension for 5 years; the highest blood pressure was 180/110?mmHg. His blood pressure was poorly controlled, 140C150/90C100?mmHg, while he took candesartan irregularly. He refused diabetes, hepatitis, tuberculosis, and coronary heart diseases. His medical family history was unremarkable. He refused use of illicit medicines and exposure to pesticides and additional toxins. Medications included an angiotensin-converting enzyme inhibitor. His excess weight was 79?kg, blood pressure was 170/90?mmHg, and physical exam was otherwise unremarkable. On admission, laboratory data showed urinary total proteinuria (URTP) 3.4?g/d, serum total protein 75.3?g/l, serum albumin (Alb)33.5?g/l, serum creatinine (Cr) 86 umol/l, (suggesting an Amadacycline methanesulfonate eGFR of 87?ml/min/1.73m2 from the CKD-EPI equation) (Fig.?1), and C-response protein (CRP) increased at 21.90?mg/l. Urinalysis showed hematuria with 482 reddish blood cells (RBC) per high-power field, with 80%.